Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment - Tan, B K; Hallschmid, M; Kern, W; Lehnert, H; Randeva, H S (J Clin Endocrinol Metab, 2011)